Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus - Witcher, Jennifer; Fleischmann, Roy; Chindalore, Vishala L.; Hansen, Ryan J.; Hu, Leijun; Radtke, David; Voelker, James; Gomez, Elisa; McColm, Juliet (British journal of clinical pharmacology, 2016)
Keywords: Adult; Aged; Antibodies, Monoclonal - administration & dosage; Antibodies, Monoclonal - adverse effects; Antibodies, Monoclonal - pharmacokinetics; Antibodies, Monoclonal, Humanized; Antigens, CD20 - immunology; Arthritis, Rheumatoid - drug therapy; B-Cell Activating Factor - antagonists & inhibitors; B-Lymphocyte Subsets - drug effects; B-Lymphocyte Subsets - immunology; B‐cell activating factor; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Lupus Erythematosus, Systemic - drug therapy; Male; Middle Aged; Pharmacokinetics; rheumatoid arthritis; systemic lupus erythematosus; tabalumab; pharmacokinetics; B-cell activating factor; systemic lupus erythematosus; tabalumab; rheumatoid arthritis